The global healthcare patent filing outsourcing market size was estimated at 1.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.5% from 2021 to 2028. Rising need for a cost-efficient and time-saving patent filing process is expected to augment the growth of the market. Growing innovations in medical devices and robust pharmaceutical and biopharmaceutical product pipelines will also drive the market over the forecast period. For instance, the number of healthcare Artificial Intelligence (AI) is on the rise. According to a report published by the World Intellectual Property Organization (WIPO) over 12,000 patents were filed as of 2018 in China.
The repercussions of the COVID-19 pandemic included disruption of patent filing processes across the world owing to shelter-in-place mandates. In 2020, the USPTO authorized an extension of 30 days under the CARES (Coronavirus Aid, Relief, and Economic Security) Act for patent filing processes with a due date between March 27 and April 27. On April 28, 2020, notices for additional extensions for due dates of patent and trademark matters were issued by the USPTO. In 2021, the USPTO assured the introduction of patents end-to-end (PE2E) search tool as well as the continuation of the pilot program of peer search collaboration.
Several start-ups are booming in the healthcare industry with new and innovative products. This will augment the market over the forecast period. Furthermore, growth in the number of patent applications by well-established players such as Novartis, Covidien, Boston Scientific, Ethicon, Olympus Corp., etc. will also drive the demand for healthcare patent filing outsourcing over the forecast period.
In January 2020 The U.S. and China went under the Economic and Trade Agreement (Phase I). This resulted in establishing a system for patent linkage while approving generic drug products. The agreement provided patent term extensions and adjustments to recompense for unreasonable delays in granting patents as well as resolved patent disputes before generic market approval. Such government initiatives will augment the need for local healthcare patent filing outsourcing companies thereby, boosting the market growth.
Patent protection plays a significant role in the pharmaceutical industry. Drug development is a time-consuming and expensive process. Therefore, such companies need patent protection to recuperate their investments as well as earn profits. Moreover, some pharmaceutical firms also use patent protection to strengthen market position and avoid competition. The aforementioned benefits of patents for pharmaceutical firms will drive the demand for healthcare patent filing outsourcing.
The medtech segment dominated the market and accounted for the largest revenue share of 51.2% in 2020. This is attributed to growing technological advancements in the medical devices industry. For instance, in 2016, Medtronic, Olympus, and Boston Scientific filed 182, 150, and 225 patents respectively. On November 6, 2020, Medtronic filed a patent for a valve delivery device that got published on February 25, 2021. Similarly, on April 17, 2020, Boston Scientific received a patent for Opticross 35 15 MHz Peripheral Imaging Catheter. Such innovations by medical device players offer huge opportunities for healthcare patent filing outsourcing.
The medtech segment is further sub-segmented into assistive care devices, consumables and disposables, diagnosis and imaging devices, drug delivery devices, surgical devices, and wearable medical devices. The wearable medical devices segment is expected to expand with the fastest CAGR over the forecast period owing to the mounting demand for such devices in telehealth services and improving health consciousness among people. The amalgamation of healthcare data and IT is the latest fad of the industry and numerous established and emerging players are trying to gain the position of first movers.
The filing and prosecution segment dominated the healthcare patent filing outsourcing market and accounted for the largest revenue share of 51.5% in 2020. This share is attributable to the complexity associated with filing and prosecution coupled with cost-efficient attained by outsourcing such tasks. In-house filing and prosecution will also waste a lot of time of internal resources. Therefore, time-saving offered by healthcare outsourcing firms in filing and prosecution will also boost the growth of the segment over the forecast period.
The pre-filing segment accounted for the second-highest share by service in 2020. Pre-filing is a crucial step in patent filing as a lot of time and money of applicants could be wasted if the step is not done by professionals with strong knowledge of the patent processes. This will in turn augment the demand for pre-filing services thus boosting the growth over the forecast period.
The resident segment dominated the market and accounted for the largest revenue share of 63.5% in 2020. Approximately, 70.0% of the overall patents registered on the WIPO repository are resident patents. However, the non-resident segment is projected to expand with a faster CAGR as filing patents in one country does not ensure protection from plagiarism in another country.
Also, the aid of local patent outsourcing firm with the know-how of local regulations is beneficial for applicants to get a patent in another country. Such factors will augment the growth of the non-resident segment over the forecast period.
Asia Pacific dominated the market and accounted for the largest revenue share of 65.5% in 2020. The region is expected to maintain its vanguard over the forecast period. The high share is attributable to the colossal number of patents filed coupled with the availability of low-cost outsourcing services in the region. A significant number of patents filed in the Asia Pacific region are from China. According to the world intellectual property organization WIPO, in 2019, China filed 1,327,847 patents while Japan and India filed 452,130 and 34,015 patents respectively.
Medical devices and pharmaceutical companies in North America and Europe outsource their patent filing processes to countries in the Asia Pacific owing to low-cost labor. This will, in turn, augment the regional growth of the market over the forecast period.
This market is highly fragmented in nature due to the presence of a substantial number of medium to small sized patent outsourcing firms. The majority of the market players are privately held. High technical know-how is required for healthcare patent filing outsourcing therefore entry barrier for new players is high. Also, large medtech and pharmaceutical players going for in-house patent filing processes might hinder the market growth. However, single point service and deep professional expertise offered by the outsourcing players will help further penetrating the in-house territory and augment market growth over the forecast period. Some of the prominent players in the healthcare patent filing outsourcing market include:
Clarivate
ipMetrix Consulting Group
CRJ IPR Services LLP
Patent Outsourcing Limited
Synoptic Intellectual Patents (P) Limited
Dennemeyer
Powell Gilbert
Bristows
Hoyng Rokh Monegier
Carpmaels & Ransford Services Limited
Report Attribute |
Details |
Market size value in 2021 |
USD 1.2 billion |
Revenue forecast in 2028 |
USD 1.8 billion |
Growth rate |
CAGR of 5.5% from 2021 to 2028 |
Base year for estimations |
2020 |
Historical data |
2016 - 2019 |
Forecast period |
2021 - 2028 |
Quantitative units |
Revenue in USD Million and CAGR from 2021 to 2028 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Domain, service, origin, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; Germany; France; U.K.; Spain; Italy; China; Japan; India; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE |
Key companies profiled |
Clarivate; ipMetrix Consulting Group; CRJ IPR Services LLP; Patent Outsourcing Limited; Synoptic Intellectual Patents (P) Limited; Dennemeyer; Powell Gilbert; Bristows; Hoyng Rokh Monegier; Carpmaels & Ransford Services Limited |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global healthcare patent filing outsourcing market on the basis of domain, service, origin, and region:
Domain Outlook (Revenue, USD Million, 2016 - 2028)
Medtech
Assistive Care devices
Consumables and Disposables
Diagnosis and Imaging Devices
Drug Delivery Devices
Surgical Devices
Wearable Medical Devices
Pharmaceutical
Service Outlook (Revenue, USD Million, 2016 - 2028)
Pre-filing
Filing & Prosecution
Post Grant
Origin Outlook (Revenue, USD Million, 2016 - 2028)
Resident
Non-resident
Regional Outlook (Revenue, USD Million, 2016 - 2028)
North America
U.S.
Canada
Europe
Germany
France
U.K.
Spain
Italy
Asia Pacific
China
Japan
India
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global healthcare patent filing outsourcing market size was estimated at USD 1.1 billion in 2020 and is expected to reach USD 1.2 billion in 2021
b. The global healthcare patent filing outsourcing market is expected to grow at a compound annual growth rate of 5.5% from 2021 to 2028 to reach USD 1.8 billion by 2028.
b. Asia Pacific region contributed for 65.5% share by region in 2020 and is expected to maintain its vanguard over the forecast period. The high share is attributable to the colossal number of patents filed coupled with the availability of low-cost outsourcing services in the region.
b. Some key players operating in the healthcare patent filing outsourcing market include Clarivate, ipMetrix Consulting Group, CRJ IPR Services LLP, Patent Outsourcing Limited, Synoptic Intellectual Patents (P) Limited, Dennemeyer, Powell Gilbert, Bristows, Hoyng Rokh Monegier, and Carpmaels & Ransford Services Limited.
b. Key factors that are driving the market growth include growing innovations in medical devices and a robust pharmaceutical & biopharmaceutical product pipeline. The rising need for a cost-efficient and time-saving patent filing process is expected to augment the growth of the healthcare patent filing outsourcing market.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
ESOMAR & Great Work to Place Certified
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."